Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06101862Recruiting
CT scan vs. angiogram for certain heart attacks
This trial compares two ways to look at heart arteries: a CT scan (noninvasive) versus a traditional angiogram (a tube put into an artery). The goal is to see which is better for people having a certain type of heart attack.
Copenhagen, HellerupAges Any age - NCT07382440Recruiting
Study of a Parkinson's treatment given under the skin
This study looks at how well a treatment called foslevodopa/foscarbidopa works for people with advanced Parkinson's disease. It is given as a shot under the skin (subcutaneous) and is already being used in clinics. The study will follow people who are already starting this treatment as part of their regular care.
Bonheiden, AntwerpenAges 18 years+ - NCT07385807Recruiting
Gut health and pregnancy in inflammatory bowel disease
This study looks at gut health in pregnant women with and without inflammatory bowel disease (IBD). It tracks a protein called calprotectin in stool samples, along with diet and baby health, to learn how IBD affects pregnancy and infant development.
Vancouver, British ColumbiaAges 19 years+ - NCT07381296Recruiting
Studying rheumatoid arthritis flare-ups
This study looks at what causes disease flares in people with rheumatoid arthritis. Researchers will track participants to find predictors of flare-ups, which could help manage the disease better.
Sohag, Sohag GovernorateAges 18 years+ - NCT07382999Recruiting
Gluten-free diet and thinking skills in teens with celiac disease
This study looks at how well teenagers with celiac disease can do two things at once, like thinking and moving, and whether sticking to a gluten-free diet helps. You will be compared to healthy teens to see if there are differences.
MalatyaAges 8–18 - NCT07383844Recruiting
Physical activity for teens with IBD
This study looks at what helps or stops teenagers with inflammatory bowel disease (Crohn's disease or ulcerative colitis) from being physically active. It involves completing questionnaires and an interview to understand your experience.
NiceAges 10–17 - NCT07386548Recruiting
Biologic injection for low back disc problems
This study tests if an injection can help people with a herniated disc in the lower back who have not gotten better with other treatments and are already planning surgery. It aims to see if the injection can reduce symptoms and possibly avoid or improve surgery outcomes.
Manhattan, New YorkAges 18 years+ - NCT07371338RecruitingPhase 1
Testing a new drug for advanced Parkinson's
This trial tests an investigational drug called IPS101A in people with advanced Parkinson's disease. It aims to see if the drug is safe and how well it works when standard treatments are no longer enough.
SeoulAges 50–80 - NCT05550324Recruiting
Pediatric heart disease patient data repository
This trial is a data repository that collects information from children with heart (cardiovascular) conditions and related syndromes. It focuses on organizing cases and comparing groups to help researchers better understand pediatric heart disease.
Columbus, OhioAges Any age - NCT06048523Recruiting
Study of genetic brain diseases
This study follows people with a confirmed genetic nerve or brain disease over time, collecting blood and sometimes spinal fluid samples to learn more about the condition. It may help researchers understand how the disease progresses.
BordeauxAges 6 years+ - NCT07368946Recruiting
Phosphate study for people with kidney disease
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
Dallas, TexasAges 18 years+ - NCT07369063RecruitingPhase 2
Vitamin D for pediatric Graves' disease
This study tests whether adding vitamin D therapy to the usual Graves' disease treatment (methimazole) can improve thyroid function and lower antibody levels in children. If your child is between 9 and 17 and recently diagnosed, they may be able to participate.
New Hyde Park, New YorkAges 9–17 - NCT07362420Recruiting
Exercise and pressure-point therapy for long-term low back pain
This study compares two treatments for low back pain that has lasted more than six weeks: a special exercise program and a hands-on therapy that targets muscle knots (trigger points). The goal is to see which approach better reduces pain and improves function.
Taipei, Taipei CityAges 18–65 - NCT07367750Recruiting
Self-management support program for chronic diseases
This trial tests a program to help people with chronic diseases manage their health better at home. If you live in the community, speak Hebrew, and have a chronic condition like diabetes or heart disease, you may be able to join.
Tel AvivAges 21 years+ - NCT07361887Recruiting
Moderate wine and healthy aging study
This study tests whether moderate wine consumption can help healthy aging by looking at tiny particles in your blood after a meal. It may help you understand how wine affects your body's cells.
Seville, SevillaAges 35–36 - NCT07362654Recruiting
Gluten challenge study in kids with celiac disease
This study looks at how the immune system of children with celiac disease responds to a small amount of gluten. It may help researchers understand the disease better and find new ways to monitor it.
MálagaAges 8–14 - NCT04970446RecruitingPhase 1/Phase 2
Fecal transplant to restore gut microbes in Crohn’s
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
Melbourne, VictoriaAges 18–70 - NCT07360977Recruiting
Broccoli supplement for Parkinson's and multiple sclerosis
This trial tests a natural compound (from broccoli sprouts) called glucoraphanin, which may help protect brain cells in people with Parkinson's disease or multiple sclerosis. It aims to see if taking this supplement can slow down or improve symptoms.
MessinaAges 1–75 - NCT07357038Recruiting
AmBisome for fungal infections in children with blood cancer
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
Tianjin, Tianjin MunicipalityAges 1 month–18 years - NCT06850597RecruitingPhase 2
Testing dimethyl fumarate for early Alzheimer's disease
This study tests a drug called dimethyl fumarate to see if it can help people with early Alzheimer's disease. It may slow down memory loss and thinking problems.
Lodz, Łódź VoivodeshipAges 55–90 - NCT06850311RecruitingPhase 2/Phase 3
Herbal ointment for mild to severe eczema
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
New Taipei CityAges 18–65 - NCT06758024Recruiting
Optimizing infliximab for inflammatory bowel disease
This trial tests whether closely monitoring and adjusting infliximab (a biologic medicine) can help people hospitalized with a moderate-to-severe flare of Crohn's disease, ulcerative colitis, or unclassified inflammatory bowel disease who haven't gotten better with IV steroids. The goal is to improve treatment response and outcomes.
SantiagoAges 18–75 - NCT04331639Recruiting
High-dose vitamin D for kids with IBD on biologic therapy
This trial studies whether giving a higher dose of vitamin D3 helps children and teens with inflammatory bowel disease (Crohn’s or ulcerative colitis) who have low vitamin D levels. Participants are already on biologic medicines and will be treated while monitoring blood (and safety) related to vitamin D.
Boston, MassachusettsAges 5–25 - NCT07348640RecruitingPhase 3
Study of new MRI dye for blocked blood vessels
This trial tests a new MRI contrast dye (gadopiclenol) to see if it works as well as the standard dye for finding blocked or narrowed blood vessels. If you have symptoms of vascular disease, you may be able to join and help compare the two dyes.
Birmingham, AlabamaAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,559 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.